Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS.

Communications Industry Interaction Medical Science Liaison Role Standards

Journal

Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411

Informations de publication

Date de publication:
11 2021
Historique:
received: 28 01 2021
accepted: 01 06 2021
pubmed: 9 7 2021
medline: 16 10 2021
entrez: 8 7 2021
Statut: ppublish

Résumé

This position paper is intended to provide recommendations that will help lay the foundation for best practices for medical science liaisons (MSLs) and their activities. Its objective is to outline the roles and responsibilities expected of an MSL and provide clarity on the juxtaposition of MSLs and Sales representatives (SRs) when it comes to scientific exchange versus promotional messaging. It is of utmost importance that industry integrity and ethical standards are assured during external stakeholder engagement as well as medical and scientific communications. This guidance, delivered through the lens of APPA, IFAPP, MAPS and the MSLS executive committees, has been prepared primarily as a supportive resource to assist the Medical Affairs teams in the industry to develop their own set of standard operating procedures (SOPs), codes of conduct and policies within the framework of relevant industry regulations. We acknowledge that whilst there are guidelines already available that provide excellent directive to the MSL function, this paper is a review and distillation of these existing recommendations combined with the perspectives of four peak professional bodies to offer a practically focused resource to help MSLs interact, collaborate and exchange scientific information appropriately with external experts when out in the field.

Identifiants

pubmed: 34236693
doi: 10.1007/s43441-021-00310-y
pii: 10.1007/s43441-021-00310-y
pmc: PMC8492581
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1139-1144

Informations de copyright

© 2021. The Author(s).

Références

Adv Med Educ Pract. 2018 Nov 02;9:777-790
pubmed: 30464675
Drug Discov Today. 2019 Sep;24(9):1865-1870
pubmed: 31158509

Auteurs

Paul Theron (P)

Head Medical Excellence APAC, Merck Healthcare Pty Ltd, 10 Mahratta Ave, Wahroonga, NSW, 2076, Australia. paul.theron@merckgroup.com.

Matthew Britland (M)

Medical Director, Amgen, Macquarie Park, Australia.

Donna Holder (D)

Senior Director, Global MSL Excellence Oncology, Daiichi Sankyo Inc, Basking Ridge, USA.

Yasushi Ikeda (Y)

Vice President, Medical Science Liaison, Astellas Pharma Inc, Tokyo, Japan.

Ralph F Rewers (RF)

National MSL Director, US Medical Affairs, AbbVie, Chicago, USA.

Ajay Tiku (A)

Regional Medical Head, Asia Pacific, Middle East and Africa, Novartis, Singapore, Singapore.

Articles similaires

Humans Mobile Applications Hepatitis C Male Female
Humans COVID-19 Male Female Adult
Humans Climate Change Health Personnel Surveys and Questionnaires Medical Oncology

Classifications MeSH